Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03468816
Other study ID # 2018-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 28, 2018
Est. completion date November 22, 2019

Study information

Verified date May 2020
Source Vårdcentralen Åby
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Explorative study of function of a moisture sensor on top of a superabsorbent wound dressing on exuding leg ulcers.


Description:

The function of a novel moisture sensor placed on a superabsorbent wound dressing has been evaluated in a small clinical investigation. Five patients with leg ulcers were included. The investigational device, Absorbest Fuktsensor, was placed on the dressing DryMax Extra Soft. Two variants of the study product were used, Variant A and Variant B. The difference between the variants were that Variant B had an extra layer of a nonwoven between the moisture sensor and the dressing in an attempt to delay the activation of the moisture sensor a little compared to Variant A which was not equipped with this nonwoven layer.

The overall aim was to observe the function of the sensor in clinical use and practical operation. Further the aim was to evaluate the two combinations of Absorbest Fuktsensor and DryMax Extra Soft and decide which combination would activate the sensor display in a satisfactory way related to the utilization of the dressings absorbing capacity while avoiding leakage and maceration.

The study was performed accordingly to ISO 14155 and the declaration of Helsinki.


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date November 22, 2019
Est. primary completion date November 22, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Presence of moderate to highly exuding leg ulcer by clinician assessment

- Wound deemed suitable for treatment with study product

- Informed consent from the participants.

Exclusion Criteria:

- Pregnancy

- Prisoner

- Bleeding from the wound

- Known allergy to components

- Wound infection

- Mental illness

- Illness or treatment of an indication other than the wound and which, according to the study personnel, can affect the wound treatment, the study and/or the dressing.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Sensor activation (on DryMax Extra Soft)
Study profile of sensor activation

Locations

Country Name City State
Sweden Hudkliniken, University hospital Linköping Region Östergötland
Sweden S2Clinic Linköping

Sponsors (7)

Lead Sponsor Collaborator
Vårdcentralen Åby Absorbest AB, S2Clinic, Linköping, Sweden, Swedish Energy Agency, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), University Hospital, Linkoeping, Vinnova

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Dressing Changes With Sensor Activation at Correct Timing Sensor activation - measured as indication on the sensor display; indication at correct time, indication but not att correct time, no indication. Inclusion visit to study completed after 3 dressing changes, 1-2 weeks
Primary Timing of Dressing Change Related to Dressing Size and Weight After Use Dressing weight after use were measured on a scale and recorded. The weight were compared to a predefined table.
Dressing size 10x10 cm:
Changed too early <11 g Correct change 11-26 g Changed too late >26 g
Dressing size 10x20 cm:
Changed too early <17 g Correct change 17-62 g Changed too late >62 g
Dressing size 20x20 cm:
Changed too early <26 g Correct change 26-109 g Changed too late >109 g
Inclusion visit to study completed after 3 dressing changes, 1-2 weeks
Secondary Complications if the Dressing Was Switched Too Late. Report of leakage, strike-through and maceration at the time for dressing changes Inclusion visit to study completed after 3 dressing changes, 1-2 weeks
Secondary Level of Usability Study the rate of handling errors Inclusion visit to study completed after 3 dressing changes, 1-2 weeks
Secondary Wound Size After Three Dressing Changes Wound size after three dressing changes with the study device, measured as cm2. Can be compared with the baseline measurement of wound size. At final dressing change no.3 (after 1-2 weeks)
See also
  Status Clinical Trial Phase
Terminated NCT05234632 - Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds N/A
Recruiting NCT04210089 - Total Contact Soft Cast in Diabetic Foot Ulcers N/A
Terminated NCT04890769 - Clinical Study of Moisture Sensor Dressing Used for Exuding Wounds
Completed NCT05564728 - Diabetes Footcare Companion App for Patients and Carers
Recruiting NCT05890703 - Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream Phase 2
Completed NCT02904707 - Interest of Skin Graft Pellets in the Management of Ulcers Algic
Terminated NCT04123093 - Safety and Efficacy of the Noxsano Wound Care Bandage N/A
Completed NCT05285930 - Effect of Bee Venom Phonophoresis on Healing of Chronic Lower Limb Ulcers N/A